Matthew Gall
Director of Finance/CFO presso ITEOS THERAPEUTICS, INC.
Patrimonio netto: 824 252 $ in data 31/03/2024
Profilo
Matthew Gall is currently the Chief Financial Officer at iTeos Therapeutics, Inc. Prior to this, he worked as the Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
He completed his undergraduate degree at Bowling Green State University and earned an MBA from The University of Chicago Booth School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
0.17% | 07/03/2024 | 60 429 ( 0.17% ) | 824 252 $ | 31/03/2024 |
Posizioni attive di Matthew Gall
| Società | Posizione | Inizio |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2020 |
Precedenti posizioni note di Matthew Gall
| Società | Posizione | Fine |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Formazione di Matthew Gall
| Bowling Green State University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
- Borsa valori
- Insiders
- Matthew Gall
